# Jiangsu Kangai Smart Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-kangai-smart-medical-technology-co

- Industry: Healthcare Specialists
- Headquarters: Beijing, China
- Website: www.ainst.com
- Latest round: Series A (Mar 28, 2024)
- Investors on record: 2

## About

Based in Beijing, China, and founded in 2011, Jiangsu Kangai Smart Medical Technology Co., Ltd. (formerly: Beijing Kangai Nutrition Technology Co., Ltd) is a healthcare company focusing on clinical operation management and patient rehabilitation. The founder Xitang Ying, has decades of experience in the medical field and founded Chemclin in 1999. In 2015, the company had a partnership with Harvard Dana-Farber Cancer Hospital. In July 2025, Beijing Kangai Nutrition Technology Co., Ltd raised a series A+ funding from new investor Jiangsu Huaian State-owned Assets Fund. The company focuses on providing cancer rehabilitation solutions for hospitals, including risk assessment before hospitalization, treatment support during treatment, continuous rehabilitation after treatment, etc. It also provides consumers with a clinical nutrition analyzer AiNST-CNDS, chronic disease outpatient nutrition solutions, and whey protein. The customer includes the Cancer Hospital of the Academy of Medical Sciences, Beijing Cancer Hospital, and other provincial tumor hospitals. In May 2025, the company changed legal name in into Jiangsu Kangai Smart Medical Technology Co., Ltd. In July 2025, the company closed a Series A+ funding from new investor Jiangsu Huaian State-owned Assets Fund.

## Funding rounds

- Series A, Mar 28, 2024 — Marathon Venture Partners
- Series A, Aug 28, 2021 — Haiyin Capital

## Investors

- Haiyin Capital (https://capitalatlas.ai/funds/haiyin-capital) — Series A
- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Series A